Product
mono-chemotherapy
1 clinical trial
1 indication
Indication
Pancreatic CancerClinical trial
A Prospective, Multicenter, Single Arm Study of SBRT Combined With Nimotuzumab and Mono-chemotherapy in the Treatment of Locally Advanced Pancreatic CancerStatus: Not yet recruiting, Estimated PCD: 2026-06-01